Sustained-release pramipexole in the treatment of Parkinson’s disease
Dopamine (DA) receptor agonists ensure stimulation of DA receptors in the brain, by compensating for dopaminergic deficiency in Parkinson’s disease (PD). Since 1996, pramipexole has been used to treat early and extensive PD stages; its clinical efficacy has been proven in many double-blind randomize...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Russo |
| Publicado: |
IMA-PRESS LLC
2012-03-01
|
| Colección: | Неврология, нейропсихиатрия, психосоматика |
| Materias: | |
| Acceso en línea: | https://nnp.ima-press.net/nnp/article/view/343 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|